'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat

Sandoz CEO Richard Saynor warned U.S. patients could ultimately bear the cost of threatened tariffs on imported generic drugs. Saynor said manufacturers facing steep tariffs could be forced to raise p...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。